Roivant Sciences Ltd.ROIVNASDAQ

Revenue (LTM)

$29M

-11.2% YoY

Net Income (LTM)

$-172M

-104.0% YoY

Free Cash Flow

$-844M

Revenue CAGR (5Y)

+5.1%

Marginsimproving

FCF($0.8B)

Now unprofitable

Metric	Mar 21	Mar 22	Mar 23	Mar 24	Mar 25
Revenue	24	55↑132.3%	61↑10.8%	33↓46.6%	29↓11.2%
Gross Profit	22	46↑113.1%	48↑4.0%	31↓35.4%	28↓9.6%
Operating Income	-1,071	-1,352↓26.2%	-1,175↑13.0%	4,497↑482.6%	-1,003↓122.3%
Net Income	-809	-845↓4.5%	-1,009↓19.4%	4,349↑531.0%	-172↓104.0%
EBITDA	-721	-911↓26.4%	-1,178↓29.3%	-803↑31.8%	-1,100↓37.0%
EPS Diluted	-1.18	-1.26↓6.8%	-1.42↓12.7%	5.23↑468.3%	-0.24↓104.6%

Metric	Mar 21	Mar 22	Mar 23	Mar 24	Mar 25
Cash & Equivalents	2,133	2,060↓3.4%	1,677↓18.6%	6,536↑289.8%	2,715↓58.5%
Total Current Assets	2,187	2,147↓1.9%	1,799↓16.2%	6,732↑274.3%	5,000↓25.7%
Total Assets	2,690	2,585↓3.9%	2,390↓7.6%	7,222↑202.2%	5,437↓24.7%
Total Current Liabilities	219	184↓15.8%	272↑47.8%	267↓2.1%	149↓44.0%
Total Liabilities	528	524↓0.8%	782↑49.3%	774↓1.0%	250↓67.7%
Total Equity	1,898	1,657↓12.7%	1,158↓30.1%	5,969↑415.5%	4,688↓21.5%
Total Debt	245	284↑15.9%	481↑69.6%	500↑3.8%	100↓80.0%
Net Debt	-1,888	-1,777↑5.9%	-1,195↑32.7%	-6,036↓404.9%	-2,615↑56.7%

Metric	Mar 21	Mar 22	Mar 23	Mar 24	Mar 25
Operating Cash Flow	-552	-678↓22.7%	-843↓24.4%	-765↑9.3%	-839↓9.7%
Capital Expenditure	-6	-17↓200.3%	-13↑27.2%	-1↑89.1%	-5↓232.8%
Free Cash Flow	-558	-695↓24.6%	-856↓23.1%	-767↑10.4%	-844↓10.1%
Stock-Based Comp	85	565↑565.0%	218↓61.5%	200↓8.3%	289↑44.8%
Net Change in Cash	-128	-68↑47.0%	-382↓464.6%	4,858↑1372.1%	-3,825↓178.7%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance